258 related articles for article (PubMed ID: 7526641)
1. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis.
Granerus G; Lönnqvist B; Roupe G
Agents Actions; 1994 Jun; 41 Spec No():C127-8. PubMed ID: 7526641
[TBL] [Abstract][Full Text] [Related]
2. Serum tryptase measured with B12 and G5 antibody-based immunoassays in mastocytosis patients and its relation to histamine turnover.
Granerus G; Lönnqvist B; Nystrand J; Roupe G
Br J Dermatol; 1998 Nov; 139(5):858-61. PubMed ID: 9892955
[TBL] [Abstract][Full Text] [Related]
3. Markers of mast cell degranulation.
Hogan AD; Schwartz LB
Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541
[TBL] [Abstract][Full Text] [Related]
5. Microdialysis of histamine in the skin of patients with mastocytosis.
Krogstad AL; Roupe G
Exp Dermatol; 2001 Apr; 10(2):118-23. PubMed ID: 11260250
[TBL] [Abstract][Full Text] [Related]
6. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
[TBL] [Abstract][Full Text] [Related]
7. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.
Schwartz LB; Sakai K; Bradford TR; Ren S; Zweiman B; Worobec AS; Metcalfe DD
J Clin Invest; 1995 Dec; 96(6):2702-10. PubMed ID: 8675637
[TBL] [Abstract][Full Text] [Related]
8. A sensitive colorimetric assay for the release of tryptase from human lung mast cells in vitro.
Lavens SE; Proud D; Warner JA
J Immunol Methods; 1993 Nov; 166(1):93-102. PubMed ID: 7693824
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells.
Veien M; Szlam F; Holden JT; Yamaguchi K; Denson DD; Levy JH
Anesthesiology; 2000 Apr; 92(4):1074-81. PubMed ID: 10754628
[TBL] [Abstract][Full Text] [Related]
10. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.
He S; Gaça MD; Walls AF
Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285
[TBL] [Abstract][Full Text] [Related]
11. Apnea as a manifestation of mast cell activation in an infant with mastocytosis.
Arnaout RK; Schwartz LB; Irani AM
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):850-1. PubMed ID: 9438498
[No Abstract] [Full Text] [Related]
12. Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis.
Kurosawa M; Amano H; Kanbe N; Igarashi Y; Nagata H; Yamashita T; Kurimoto F; Miyachi Y
J Allergy Clin Immunol; 1999 May; 103(5 Pt 2):S412-20. PubMed ID: 10329843
[TBL] [Abstract][Full Text] [Related]
13. Mast cell tryptase: a review of its physiology and clinical significance.
Payne V; Kam PC
Anaesthesia; 2004 Jul; 59(7):695-703. PubMed ID: 15200544
[TBL] [Abstract][Full Text] [Related]
14. Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels.
Biedermann T; Ruëff F; Sander CA; Przybilla B
Br J Dermatol; 1999 Dec; 141(6):1110-2. PubMed ID: 10606862
[TBL] [Abstract][Full Text] [Related]
15. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P
J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387
[TBL] [Abstract][Full Text] [Related]
16. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.
He S; Gaça MD; Walls AF
J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871
[TBL] [Abstract][Full Text] [Related]
17. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.
He S; Walls AF
Eur J Pharmacol; 1997 Jun; 328(1):89-97. PubMed ID: 9203574
[TBL] [Abstract][Full Text] [Related]
18. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
Butterfield JH; Weiler CR
Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
[TBL] [Abstract][Full Text] [Related]
19. Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood.
Ghildyal N; Friend DS; Stevens RL; Austen KF; Huang C; Penrose JF; Sali A; Gurish MF
J Exp Med; 1996 Sep; 184(3):1061-73. PubMed ID: 9064323
[TBL] [Abstract][Full Text] [Related]
20. Surrogate markers of disease in mastocytosis.
Akin C; Metcalfe DD
Int Arch Allergy Immunol; 2002 Feb; 127(2):133-6. PubMed ID: 11919423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
